Risk factors associated with readmissions of patients with severe mental disorders under treatment with antipsychotics
Date
2022-03-17
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Abstract
Background
The aim of this study was to assess the risk of readmission in patients with severe mental disorders, compare it between patients using different types of antipsychotics and determine risk factors for psychiatric readmission.
Methods
Medical records of a non-concurrent cohort of 625 patients with severe mental disorders (such as psychoses and severe mood disorders) who were first discharged from January to December 2012 (entry into the cohort), with longitudinal follow-up until December 2017 constitute the sample. Descriptive statistical analysis of characteristics of study sample was performed. The risk factors for readmission were assessed using Cox regression.
Results
Males represented 51.5% of the cohort, and 75.6% of the patients had no partner. Most patients (89.9%) lived with relatives, and 64.7% did not complete elementary school. Only 17.1% used more than one antipsychotic, 34.2% did not adhere to the treatment, and 13.9% discontinued the medication due to unavailability in public pharmacies. There was a need to change the antipsychotic due to the lack of therapeutic response (11.2% of the patients) and adverse reactions to the antipsychotic (5.3% of the patients). Cox regression showed that the risk of readmission was increased by 25.0% (RR, 1.25; 95% CI, 1.03–1.52) when used typical antipsychotics, compared to those who used atypical ones, and by 92.0% (RR, 1.92; 95% CI, 1.63–2.27) when patients did not adhere to maintenance treatment compared to those who adhered.
Conclusions
Use of atypical antipsychotics and adherence to treatment were associated with a lower risk of psychiatric readmissions.
Description
Keywords
Citation
BMC Psychiatry. 2022 Mar 17;22(1):189
DOI
https://doi.org/10.1186/s12888-022-03794-6
ISSN
Creative Commons
Creative Commons URI
Collections
Items in TSpace are protected by copyright, with all rights reserved, unless otherwise indicated.